Related Experiment Video
Updated: Aug 10, 2026
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Suppressive effects of alprazolam on the immune response of mice
M P Chang1, S C Castle, D C Norman
1Geriatric Research, Education and Clinical Center, VA Medical Center West Los Angeles, CA 90073.
Insights
Alprazolam significantly suppresses immune cell responses in mice. This study shows it inhibits T-cell and B-cell proliferation and reduces key cytokine production, indicating potent immunosuppressive effects.
Area of Science:
- Immunology
- Pharmacology
Background:
- Alprazolam is a commonly prescribed benzodiazepine.
- Its effects on the immune system are not fully understood.
Purpose of the Study:
- To investigate the impact of alprazolam on murine immune cell function.
- To assess its effects on T-cell and B-cell proliferation and cytokine production.
Main Methods:
- Murine splenic cells were stimulated with mitogens (Concanavalin A, lipopolysaccharide) in the presence of alprazolam.
- Peritoneal macrophages were stimulated with lipopolysaccharide and cultured with alprazolam.
- Assessed T-cell proliferation, B-cell proliferation, and production of interleukin-2, interleukin-1, and tumor necrosis factor.
Main Results:
- Alprazolam demonstrated potent immunosuppressive activity.
- It inhibited concanavalin A-induced T-cell proliferation and lipopolysaccharide-induced B-cell proliferation.
- Alprazolam reduced the production of interleukin-2, interleukin-1, and tumor necrosis factor.
- Immunosuppression was dose-dependent, with B-cells being more sensitive than T-cells.
Conclusions:
- Alprazolam acts as a potent immunosuppressive agent.
- It negatively impacts key components of the innate and adaptive immune responses.
- Further research is warranted to understand the clinical implications of these findings.
Abstract:
The purpose of this study was to examine the effects of alprazolam on the response of murine immune cells. Splenic cells of young BALB/c mice were first cultured with an optimum dose of various mitogens in the presence or absence of varying doses of alprazolam to assess effects of alprazolam on concanavalin A (Con A)-induced T-cell proliferation, bacterial lipopolysaccharide (LPS)-induced B-cell proliferation, and production of interleukin 2 (IL2). Then, peritoneal adherent cells (macrophages) from young BALB/c mice were cultured with an optimum dose of LPS in the presence or absence of alprazolam to assess the effects of alprazolam on the ability of peritoneal adherent cells to produce interleukin 1 (IL1) and tumor necrosis factor (TNF). The results of this study clearly demonstrated that alprazolam is a potent immunosuppressive agent that can inhibit the proliferative responses of both B- and T-cells to LPS and Con A, respectively. It also can reduce production of IL2 by splenic T-cells and production of both IL1 and TNF by peritoneal macrophages. Furthermore, it was also shown that (a) the magnitude of suppression of T-cell proliferation and of IL2 production occurs in a dose-dependent manner and (b) B-cells are more vulnerable than T-cells to the effect of alprazolam.
